TM

Tarun Mehta

Active Director Director DIN 10097734
DIN 10097734 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Tarun Mehta

Data last updated:

Tarun Mehta is a Director at Ekansh Pharma India Private Limited (since 2023). The company operates in Paper. Ekansh Pharma India Private Limited reported revenue of ₹2.1 Lakh (FY 2024).

DIN 10097734
Primary Designation Director
Industry Paper
First Appointment 31 Mar 2023
Oldest Company Age 3 yrs
Largest company Ekansh Pharma India Private Limited · ₹2.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ekansh Pharma India Private Limited U21002HR2023PTC110383
Director31 Mar 20232023₹2.1 Lakh (FY 2024)Active

Board colleagues of Tarun Mehta

NameDINCompanyDesignation
Mukesh Sharma10097733Ekansh Pharma India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ekansh Pharma India Private Limited
Premium access

Shareholding and investment profile for Tarun Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tarun Mehta

Tarun Mehta currently holds 1 directorship: Ekansh Pharma India Private Limited (Director, since 31 Mar 2023, revenue ₹2.1 Lakh (FY 2024)).

Tarun Mehta was first appointed on 31 Mar 2023 as Director at Ekansh Pharma India Private Limited.

The current boards of Tarun Mehta's companies include Mukesh Sharma (Ekansh Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available